Trade Names:
Synonyms:
Status: Approved (2009)
Entry Type: Protein
Molecule Category: UNKNOWN
ATC: B06AC03
UNII: 5Q6TZN2HNM

Pharmacology

Action Mechanism of Action Reference
INHIBITOR Plasma kallikrein inhibitor DailyMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Angioedema 2 D000799 ClinicalTrials

Side Effects from Label

Adverse Reactions

System Organ Classification (SOC)
Relative Frequency (%)
Skin and subcutaneous tissue disorders
13.97
General disorders and administration site conditions
12.74
Immune system disorders
12.2
Injury, poisoning and procedural complications
8.89
Congenital, familial and genetic disorders
8.12
Gastrointestinal disorders
6.33
Respiratory, thoracic and mediastinal disorders
6.27
Nervous system disorders
4.96
Infections and infestations
4.4
Vascular disorders
4.31
Musculoskeletal and connective tissue disorders
3.38
Cardiac disorders
2.84
Psychiatric disorders
2.76
Investigations
2.74

Cross References

Resources Reference
CAS NUMBER 460738-38-9
ChEMBL CHEMBL1201837
FDA SRS 5Q6TZN2HNM
Guide to Pharmacology 6955
PubChem 118984459